JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
 QUICK SEARCH:   [advanced]


     


First published online February 20, 2008
J Nucl Med 2008, doi:10.2967/jnumed.107.047787
© 2008 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.107.047787v1
49/3/480    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fletcher, J. W.
Right arrow Articles by Shields, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fletcher, J. W.
Right arrow Articles by Shields, A. F.


Recommendations on the Use of 18F-FDG PET in Oncology

James W. Fletcher 1*, Benjamin Djulbegovic 2, Heloisa P. Soares 2, Barry A. Siegel 3, Val J. Lowe 4, Gary H. Lyman 5, R. Edward Coleman 5, Richard Wahl 6, John Christopher Paschold 7, Norbert Avril 8, Lawrence H. Einhorn 1, W. Warren Suh 9, David Samson 10, Dominique Delbeke 11, Mark Gorman 12, and Anthony F. Shields 13

1 Indiana University School of Medicine, Indianapolis, Indiana
2 H. Lee Moffitt Cancer Center at University of South Florida, Tampa, Florida
3 Washington University School of Medicine, St. Louis, Missouri
4 Mayo Clinic, Rochester, Minnesota
5 Duke University Medical Center, Durham, North Carolina
6 Johns Hopkins Medical Center, Baltimore, Maryland
7 US Oncology, Newport News, Virginia
8 Queen Mary's School of Medicine and Dentistry, London, United Kingdom
9 Brigham and Women's Hospital, Boston, Massachusetts
10 Blue Cross and Blue Shield Association, Washington, DC
11 Vanderbilt University Medical Center, Nashville, Tennessee
12 National Coalition for Cancer Survivorship, Washington, DC
13 Karmanos Cancer Institute, Detroit, Michigan

* To whom correspondence should be addressed. E-mail: wfletch{at}iupui.edu.


   Abstract

The rationale was to develop recommendations on the use of 18F-FDG PET in breast, colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, melanoma, and sarcoma; and unknown primary tumor. Outcomes of interest included the use of 18F-FDG PET for diagnosing, staging, and detecting the recurrence or progression of cancer. Methods: A search was performed to identify all published randomized controlled trials and systematic reviews in the literature. An additional search was performed to identify relevant unpublished systematic reviews. These publications comprised both retrospective and prospective studies of varied methodologic quality. The anticipated consequences of false-positive and false-negative tests when evaluating clinical usefulness, and the impact of 18F-FDG PET on the management of cancer patients, were also reviewed. Results and Conclusion: 18F-FDG PET should be used as an imaging tool additional to conventional radiologic methods such as CT or MRI; any positive finding that could lead to a clinically significant change in patient management should be confirmed by subsequent histopathologic examination because of the risk of false-positive results. 18F-FDG PET should be used in the appropriate clinical setting for the diagnosis of head and neck, lung, or pancreatic cancer and for unknown primary tumor. PET is also indicated for staging of breast, colon, esophageal, head and neck, and lung cancer and of lymphoma and melanoma. In addition, 18F-FDG PET should be used to detect recurrence of breast, colorectal, head and neck, or thyroid cancer and of lymphoma.

Key Words: oncology, PET, 18F-FDG PET




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
A. K. Buck, K. Herrmann, T. Stargardt, T. Dechow, B. J. Krause, and J. Schreyogg
Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
J. Nucl. Med. Technol., March 1, 2010; 38(1): 6 - 17.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. K. Buck, K. Herrmann, T. Stargardt, T. Dechow, B. J. Krause, and J. Schreyogg
Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
J. Nucl. Med., March 1, 2010; 51(3): 401 - 412.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. G.C. Troost, D. A.X. Schinagl, J. Bussink, O. C. Boerman, A. J. van der Kogel, W. J.G. Oyen, and J. H.A.M. Kaanders
Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET
J. Nucl. Med., January 1, 2010; 51(1): 66 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
J. P. Gambini, M. Nunez, P. Cabral, M. Lafferranderie, J. Noble, E. Corchs, R. D'Albora, E. Savio, L. Delgado, and O. Alonso
Evaluation of Patients with Head and Neck Cancer by Means of 99mTc-Glucarate
J. Nucl. Med. Technol., December 1, 2009; 37(4): 229 - 232.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
U. Petrausch, P. Samaras, P. Veit-Haibach, A. Tschopp, J. D. Soyka, A. Knuth, T. F. Hany, A. Mischo, C. Renner, and N. G. Schaefer
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?
Ann. Onc., November 13, 2009; (2009) mdp519v1.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
B. Glimelius, M. Lahn, S. Gawande, A. Cleverly, C. Darstein, L. Musib, Y. Liu, K. L. Spindler, J.-E. Frodin, A. Berglund, et al.
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
Ann. Onc., November 9, 2009; (2009) mdp521v1.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. C. Ford, J. Herman, E. Yorke, and R. L. Wahl
18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
J. Nucl. Med., October 1, 2009; 50(10): 1655 - 1665.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. J. McBride, R. M. Sharkey, H. Karacay, C. A. D'Souza, E. A. Rossi, P. Laverman, C.-H. Chang, O. C. Boerman, and D. M. Goldenberg
A Novel Method of 18F Radiolabeling for PET
J. Nucl. Med., June 1, 2009; 50(6): 991 - 998.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. J. Krause, K. Herrmann, H. Wieder, and C. M. zum Buschenfelde
18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
J. Nucl. Med., May 1, 2009; 50(Suppl_1): 89S - 96S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. Boellaard
Standards for PET Image Acquisition and Quantitative Data Analysis
J. Nucl. Med., May 1, 2009; 50(Suppl_1): 11S - 20S.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
B. Huang, M. W.-M. Law, and P.-L. Khong
Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk
Radiology, April 1, 2009; 251(1): 166 - 174.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
H. W.M. VAN LAARHOVEN, M. VINKEN, R. MUS, U. FLUCKE, W. J.G. OYEN, and W. T. VAN DER GRAAF
The Diagnostic Hurdle of an Elderly Male with Bone Pain: How 18F-FDG-PET Led to Diagnosis of a Leiomyosarcoma of the Adrenal Gland
Anticancer Res, February 1, 2009; 29(2): 469 - 472.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Morikawa, Y. Demura, T. Ishizaki, S. Ameshima, I. Miyamori, M. Sasaki, T. Tsuchida, H. Kimura, Y. Fujibayashi, and H. Okazawa
The Effectiveness of 18F-FDG PET/CT Combined with STIR MRI for Diagnosing Nodal Involvement in the Thorax
J. Nucl. Med., January 1, 2009; 50(1): 81 - 87.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
K.-Y. Chang, J.-Y. Chang, J. Chao, and Y. Yen
Modern Staging and Utility of PET Imaging in Esophageal Cancer Management
J Natl Compr Canc Netw, October 1, 2008; 6(9): 862 - 869.
[Abstract] [PDF]


Home page
Mayo Clin Proc.Home page
N. I. Khushalani
Cancer of the Esophagus and Stomach
Mayo Clin. Proc., June 1, 2008; 83(6): 712 - 722.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.